Cannabis company Vireo Growth's Q4 revenue surges on M&A deals
Overview
U.S. cannabis operator's Q4 revenue rose 318% yr/yr, driven by recent M&A deals
Company announced pending acquisitions of Eaze, Schwazze, PharmaCann assets, and MOU for Hawthorne
Q4 adjusted EBITDA grew 347% yr/yr as company realized synergies from recent integrations
Outlook
Vireo Growth expects pending acquisitions to close in first half of 2026
Result Drivers
M&A ACTIVITY - Q4 revenue surge attributed to recently closed mergers and acquisitions expanding retail and wholesale footprint
SAME STORE SALES - Pro forma same store sales increased 22% yr/yr
SYNERGIES FROM INTEGRATION - Company realized corporate overhead synergies following integration of Deep Roots, Proper, and Wholesome acquisitions
Company press release: ID:nGNX6FxxQw
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q4 Revenue |
| $104.50 mln |
|
Q4 Gross Profit |
| $56.90 mln |
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
